Prognostic impact of genomic instability in colorectal cancer

Background: The prognostic impact of an indication of chromosomal instability (CIN) is evaluated in a consecutive series of 952 colorectal cancer patients treated at Aker University Hospital, Norway, during 1993–2003. Microsatellite instability (MSI) in this case series has recently been reported an...

Full description

Saved in:
Bibliographic Details
Published inBritish journal of cancer Vol. 110; no. 8; pp. 2159 - 2164
Main Authors Hveem, T S, Merok, M A, Pretorius, M E, Novelli, M, Bævre, M S, Sjo, O H, Clinch, N, Liestøl, K, Svindland, A, Lothe, R A, Nesbakken, A, Danielsen, H E
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 15.04.2014
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background: The prognostic impact of an indication of chromosomal instability (CIN) is evaluated in a consecutive series of 952 colorectal cancer patients treated at Aker University Hospital, Norway, during 1993–2003. Microsatellite instability (MSI) in this case series has recently been reported and made it possible to find the co-occurrence and compare the prognostic significance of CIN and MSI. Methods: Data sets for overall survival (OS; n =855) and time to recurrence (TTR; n =579) were studied. To reveal CIN we used automated image cytometry (ICM). Non-diploid histograms were taken as indicative of the presence of CIN. PCR-based measures of MSI in this material have already been described. Results: As with MSI, CIN was found to be an independent predictor of early relapse and death among stage II patients (TTR: n =278: HR 2.19 (95% CI: 1.35–3.55), P =0.002). Of the MSI tumours (16%), 71% were found to be DNA diploid, 21% were DNA tetraploid and 8% were DNA aneuploid. Among microsatellite stable tumours, 24% were DNA diploid, 15% were DNA tetraploid and 61% were DNA aneuploid. Conclusion: For patients presenting with stage II disease, genomic instability as detected by DNA image cytometry has the potential to provide a useful biomarker for relapse and cancer-related death following surgery with curative intent.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0007-0920
1532-1827
DOI:10.1038/bjc.2014.133